NAMS icon

NewAmsterdam Pharma

Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$45
28% upside
High target

5 analyst ratings

positive
neutral
20%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Guggenheim
Guggenheim
Debjit Chattopadhyay
0% 1-yr NAMS win rate
19 Feb ‘26 10 days ago
Needham
Needham
Serge Belanger
80% 1-yr NAMS win rate
18 Feb ‘26 11 days ago
RBC Capital
RBC Capital
Leonid Timashev
67% 1-yr NAMS win rate
21 Jan ‘26 1 month ago
Stifel
Stifel
James Condulis
100% 1-yr NAMS win rate
16 Dec ‘25 2 months ago
Goldman Sachs
Goldman Sachs
Asad Haider
2 Dec ‘25 2 months ago